FDA Releases Draft Guidance on Disclosure of Conflicts of Interest for Special Government Employees on FDA Advisory Committees

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining a new policy requiring the disclosure of specific financial interests that give rise to conflict of interest waivers for special government employees participating in FDA product-specific advisory committees.